Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Gale

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Journal of the American Society of Nephrology : JASN|January 11, 2020
Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 GlomerulopathyAdam P Levine, Melanie M Y Chan, Omid Sadeghi-Alavijeh, et al.
Kidney International Reports|December 19, 2024
SGLT2-Inhibition in Patients With Alport SyndromeJan Boeckhaus, Daniel P Gale, James Simon, et al.
Kidney International|May 11, 2020
Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathyVicky Brocklebank, Gurinder Kumar, Alexander J Howie, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 3, 2024
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work GroupCarla Nester, Dima A Decker, Matthias Meier, et al.
Kidney International|May 26, 2020
Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1Eric Olinger, Patrick Hofmann, Kendrah Kidd, et al.
The New England Journal of Medicine|December 3, 2025
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGNFadi Fakhouri, Andrew S Bomback, Gema Ariceta, et al.
Journal of the American Society of Nephrology : JASN|July 3, 2019
Genetic Identification of Two Novel Loci Associated with Steroid-Sensitive Nephrotic SyndromeStephanie Dufek, Chris Cheshire, Adam P Levine, et al.
Kidney International Reports|December 18, 2023
Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA NephropathyFrederick W K Tam, James Tumlin, Jonathan Barratt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport SyndromeOliver Gross, Clifford E Kashtan, Michelle N Rheault, et al.
Lancet (London, England)|March 16, 2024
Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohortKatie Wong, David Pitcher, Fiona Braddon, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Journal of the American Society of Nephrology : JASN|January 11, 2020
Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 GlomerulopathyAdam P Levine, Melanie M Y Chan, Omid Sadeghi-Alavijeh, et al.
Kidney International Reports|December 19, 2024
SGLT2-Inhibition in Patients With Alport SyndromeJan Boeckhaus, Daniel P Gale, James Simon, et al.
Kidney International|May 11, 2020
Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathyVicky Brocklebank, Gurinder Kumar, Alexander J Howie, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 3, 2024
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work GroupCarla Nester, Dima A Decker, Matthias Meier, et al.
Kidney International|May 26, 2020
Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1Eric Olinger, Patrick Hofmann, Kendrah Kidd, et al.
The New England Journal of Medicine|December 3, 2025
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGNFadi Fakhouri, Andrew S Bomback, Gema Ariceta, et al.
Journal of the American Society of Nephrology : JASN|July 3, 2019
Genetic Identification of Two Novel Loci Associated with Steroid-Sensitive Nephrotic SyndromeStephanie Dufek, Chris Cheshire, Adam P Levine, et al.
Kidney International Reports|December 18, 2023
Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA NephropathyFrederick W K Tam, James Tumlin, Jonathan Barratt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport SyndromeOliver Gross, Clifford E Kashtan, Michelle N Rheault, et al.
Lancet (London, England)|March 16, 2024
Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohortKatie Wong, David Pitcher, Fiona Braddon, et al.
Pageof 12